Related Experiment Videos
Ischemic ST-segment changes after dipyridamole infusion
Insights
Dipyridamole infusion thallium-201 myocardial imaging detects coronary artery disease. Combining imaging with ST-segment changes improves non-invasive test sensitivity for chest pain syndromes.
Area of Science:
- Cardiology
- Nuclear Cardiology
- Diagnostic Imaging
Background:
- Chest pain syndromes necessitate accurate diagnosis of coronary arterial disease.
- Non-invasive tests are crucial for evaluating patients with suspected coronary artery disease.
Purpose of the Study:
- To evaluate the diagnostic utility of thallium-201 myocardial imaging combined with dipyridamole infusion for detecting coronary arterial disease.
- To assess the significance of ST-segment changes during dipyridamole stress testing.
Main Methods:
- Thirty consecutive patients with chest pain underwent thallium-201 myocardial imaging post-dipyridamole infusion.
- Coronary angiography was performed for comparison.
- Visual analysis of myocardial perfusion imaging and electrocardiographic ST-segment changes were analyzed.
Main Results:
- Eight patients (27%) exhibited ischemic ST-segment changes following dipyridamole infusion.
- All patients with ST-segment changes demonstrated significant coronary arterial disease on angiography.
- Thallium-201 myocardial imaging revealed perfusion defects consistent with ischemia.
Conclusions:
- Dipyridamole-induced thallium-201 myocardial imaging is a valuable non-invasive tool for diagnosing coronary arterial disease.
- The addition of ST-segment analysis to dipyridamole stress testing enhances the sensitivity of this diagnostic approach.
- This combined method offers improved detection of significant coronary arterial disease in patients presenting with chest pain.
Abstract:
Thirty consecutive patients were studied by thallium-201 myocardial imaging after dipyridamole infusion and by coronary angiography because of syndromes of chest pain. Eight patients (27%) had ischemic ST-segment changes after the infusion of dipyridamole. They all had significant coronary arterial disease. It is suggested that the combination of visual analysis of myocardial imaging and analysis of ST-segment changes be used after dipyridamole infusion to improve the sensitivity of this non-invasive test.